Exploring how engineered bacteria are revolutionizing RNAi therapy delivery through TransKingdom RNAi technology
Breakthrough approach using engineered aptamers to control miRNA production at its source, pioneering a new era of RNA-targeted therapy.
Discover how scientists produce pig interleukin-2 (IL-2) in E. coli for immune research and potential medical applications.
Discover how targeting the Slug (SNAI2) gene could revolutionize neuroblastoma treatment by facilitating apoptosis and inhibiting invasive growth in childhood cancers.
Exploring how machine learning is transforming our understanding of RNA biology through advanced data analysis and pattern recognition.
Discover how miR-34a in dogs could transform osteosarcoma treatment for both pets and humans through groundbreaking comparative oncology research.
Discover how pan-selective aptamers are revolutionizing targeting of small GTPases, previously considered undruggable, with potential applications in cancer and neurodegenerative diseases.
Breakthrough research on Imetelstat's efficacy in treating JAKi-refractory myelofibrosis patients with unprecedented survival benefits and disease modification potential
Exploring the groundbreaking science of circulating tumor cells (CTCs) and how they're transforming cancer diagnosis and treatment through liquid biopsies.
Discover how MALAT-1 lncRNA drives non-small cell lung cancer progression and serves as a powerful prognostic biomarker in this comprehensive scientific review.